import type { Medication } from '../types';

export const defaultMedications: Medication[] = [
  // SSRIs
  {
    id: 'sertraline',
    name: 'Sertraline',
    genericName: 'Zoloft',
    tags: ['SSRI', 'Antidepressant', 'First-line'],
    class: 'SSRI',
    indications: ['Major Depressive Disorder', 'Panic Disorder', 'PTSD', 'OCD', 'Social Anxiety Disorder', 'Premenstrual Dysphoric Disorder'],
    quickFlags: ['First-line', 'Pregnancy-safe', 'QT-safe', 'Weight-neutral'],
    dosing: {
      adult: {
        start: '25-50 mg/day',
        titration: 'Increase by 25-50 mg every 1-2 weeks',
        maintenance: '50-200 mg/day',
        max: '200 mg/day (300 mg off-label for OCD)',
      },
      geriatric: {
        start: '25 mg/day',
        maintenance: '25-100 mg/day',
        notes: 'Start low, go slow. Monitor for hyponatremia.',
      },
      renal: 'No adjustment needed',
      hepatic: 'Reduce dose or increase interval',
      notes: 'Take with food to reduce GI upset. Morning dosing preferred (activating).',
    },
    warnings: [
      'Black Box: Increased risk of suicidal thinking in young adults',
      'Serotonin Syndrome risk with other serotonergic agents',
      'Discontinuation syndrome if stopped abruptly',
    ],
    sideEffects: [
      { effect: 'Nausea', frequency: 'very-common', management: 'Take with food' },
      { effect: 'Headache', frequency: 'common' },
      { effect: 'Insomnia', frequency: 'common', management: 'Morning dosing' },
      { effect: 'Sexual dysfunction', frequency: 'common', management: 'Dose reduction, switch to bupropion' },
      { effect: 'Diarrhea', frequency: 'common' },
    ],
    cautions: {
      renal: 'No adjustment',
      hepatic: 'Use lower doses',
      bipolar: 'May induce mania - screen for bipolar disorder',
      other: ['Bleeding risk with NSAIDs/anticoagulants', 'Hyponatremia in elderly'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: 'Wait 14 days after MAOI discontinuation' },
      { drug: 'Pimozide', severity: 'contraindicated', mechanism: 'Increased pimozide levels', recommendation: 'Avoid combination' },
      { drug: 'Warfarin', severity: 'moderate', mechanism: 'Increased bleeding risk', recommendation: 'Monitor INR closely' },
      { drug: 'NSAIDs', severity: 'moderate', mechanism: 'Increased bleeding risk', recommendation: 'Use PPI or consider alternative' },
      { drug: 'Tramadol', severity: 'major', mechanism: 'Serotonin syndrome risk', recommendation: 'Monitor closely or avoid' },
    ],
    clinicalPearls: [
      'Least sexual side effects among SSRIs',
      'Preferred in cardiovascular patients due to minimal drug interactions',
      'May be preferred in post-MI depression',
      'FDA approved for multiple anxiety disorders',
    ],
    monitoring: [
      { parameter: 'Baseline symptoms (PHQ-9)', baseline: true, followUp: 'PHQ-9 every 2-4 weeks initially', frequency: 'Every visit until stable' },
      { parameter: 'Weight', baseline: true, followUp: 'Monitor for changes', frequency: 'Monthly x 3, then quarterly' },
      { parameter: 'Sodium (elderly)', baseline: true, followUp: 'Check if symptomatic', frequency: 'At 2 weeks in elderly' },
    ],
    titrationSchedule: [
      { week: 1, dose: '25-50 mg', notes: 'Start 25mg if anxiety predominant' },
      { week: 2, dose: '50 mg', notes: 'Increase to 50mg if tolerated' },
      { week: 4, dose: '50-100 mg', notes: 'Assess response' },
      { week: 6, dose: '100-200 mg', notes: 'Increase if partial response' },
    ],
    equivalents: [
      { fromDrug: 'Fluoxetine 20mg', fromDose: '20 mg', toDose: '50 mg' },
      { fromDrug: 'Escitalopram 10mg', fromDose: '10 mg', toDose: '50 mg' },
      { fromDrug: 'Paroxetine 20mg', fromDose: '20 mg', toDose: '50 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016', 'APA Practice Guidelines 2023'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'escitalopram',
    name: 'Escitalopram',
    genericName: 'Cipralex / Lexapro',
    tags: ['SSRI', 'Antidepressant', 'First-line'],
    class: 'SSRI',
    indications: ['Major Depressive Disorder', 'Generalized Anxiety Disorder', 'Panic Disorder', 'Social Anxiety Disorder'],
    quickFlags: ['First-line', 'QT-caution', 'Weight-neutral'],
    dosing: {
      adult: {
        start: '10 mg/day',
        titration: 'May increase to 20 mg after 1-2 weeks',
        maintenance: '10-20 mg/day',
        max: '20 mg/day',
      },
      geriatric: {
        start: '5 mg/day',
        maintenance: '5-10 mg/day',
        notes: 'Start 5mg in elderly. Higher doses not recommended.',
      },
      renal: 'No adjustment',
      hepatic: 'Start 5 mg/day, max 10 mg/day',
      notes: 'Morning or evening dosing. Allosteric serotonin reuptake inhibitor.',
    },
    warnings: [
      'Black Box: Suicidal thinking in young adults',
      'QT prolongation at higher doses',
      'Do not exceed 20 mg/day (no additional benefit)',
    ],
    sideEffects: [
      { effect: 'Nausea', frequency: 'common' },
      { effect: 'Sexual dysfunction', frequency: 'common' },
      { effect: 'Insomnia or somnolence', frequency: 'common' },
      { effect: 'Sweating', frequency: 'common' },
    ],
    cautions: {
      hepatic: 'Reduce dose',
      cardiac: 'QT prolongation risk',
      other: ['CYP2C19 poor metabolizers may have higher levels'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: '14-day washout' },
      { drug: 'QT prolonging drugs', severity: 'major', mechanism: 'Additive QT effect', recommendation: 'Avoid or monitor ECG' },
    ],
    clinicalPearls: [
      'Most selective SSRI - theoretically fewer side effects',
      'No significant CYP450 interactions',
      'Effective at 10mg for most patients',
      'May have faster onset than other SSRIs',
    ],
    monitoring: [
      { parameter: 'PHQ-9/GAD-7', baseline: true, followUp: 'Every 2-4 weeks', frequency: 'Until stable' },
      { parameter: 'ECG', baseline: false, followUp: 'If cardiac risk or on other QT drugs', frequency: 'As needed' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'low',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'fluoxetine',
    name: 'Fluoxetine',
    genericName: 'Prozac',
    tags: ['SSRI', 'Antidepressant', 'Activating'],
    class: 'SSRI',
    indications: ['Major Depressive Disorder', 'OCD', 'Bulimia Nervosa', 'Panic Disorder', 'Premenstrual Dysphoric Disorder'],
    quickFlags: ['Activating', 'Weight-loss', 'QT-safe'],
    dosing: {
      adult: {
        start: '20 mg/day',
        titration: 'Increase by 10-20 mg every 2-4 weeks',
        maintenance: '20-60 mg/day',
        max: '80 mg/day (OCD)',
      },
      geriatric: {
        start: '10 mg/day',
        maintenance: '10-40 mg/day',
        notes: 'Long half-life beneficial for adherence',
      },
      notes: 'Long half-life (t1/2 = 1-3 days, norfluoxetine 4-16 days)',
    },
    warnings: [
      'Black Box: Suicidal thinking',
      'Long half-life complicates switching to other antidepressants',
      'Activating - may worsen anxiety initially',
    ],
    sideEffects: [
      { effect: 'Insomnia', frequency: 'common', management: 'Morning dosing' },
      { effect: 'Anxiety/Activation', frequency: 'common', management: 'Start low in anxiety patients' },
      { effect: 'Appetite suppression', frequency: 'common' },
      { effect: 'Sexual dysfunction', frequency: 'common' },
    ],
    cautions: {
      seizure: 'Lowers seizure threshold',
      other: ['May worsen bipolar mania'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: 'Wait 5 weeks after fluoxetine discontinuation' },
      { drug: 'Tramadol', severity: 'major', mechanism: 'Serotonin syndrome', recommendation: 'Avoid or monitor' },
      { drug: 'TCAs', severity: 'moderate', mechanism: 'Inhibits CYP2D6', recommendation: 'Reduce TCA dose' },
    ],
    clinicalPearls: [
      'Long half-life useful for patients with adherence issues',
      'Preferred in pediatric OCD',
      'May be helpful in atypical depression with fatigue/hypersomnia',
      'Useful for sequential administration (weekend dosing)',
    ],
    monitoring: [
      { parameter: 'PHQ-9', baseline: true, followUp: 'Every 2-4 weeks', frequency: 'Until stable' },
      { parameter: 'Weight', baseline: true, followUp: 'Monitor for weight loss', frequency: 'Monthly' },
    ],
    equivalents: [
      { fromDrug: 'Sertraline 50mg', fromDose: '50 mg', toDose: '20 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'paroxetine',
    name: 'Paroxetine',
    genericName: 'Paxil',
    tags: ['SSRI', 'Antidepressant', 'Sedating'],
    class: 'SSRI',
    indications: ['Major Depressive Disorder', 'Panic Disorder', 'Social Anxiety Disorder', 'GAD', 'PTSD', 'OCD', 'Premenstrual Dysphoric Disorder'],
    quickFlags: ['Sedating', 'Weight-gain', 'QT-safe'],
    dosing: {
      adult: {
        start: '20 mg/day',
        titration: 'Increase by 10 mg weekly',
        maintenance: '20-50 mg/day (IR) or 25-62.5 mg/day (CR)',
        max: '60 mg/day (IR), 75 mg/day (CR)',
      },
      geriatric: {
        start: '10 mg/day',
        maintenance: '10-40 mg/day',
        notes: 'Higher anticholinergic effects in elderly',
      },
      notes: 'IR causes more GI upset; CR better tolerated',
    },
    warnings: [
      'Highest risk of discontinuation syndrome among SSRIs',
      'More anticholinergic effects than other SSRIs',
      'Weight gain more common',
    ],
    sideEffects: [
      { effect: 'Sedation', frequency: 'common', management: 'Evening dosing' },
      { effect: 'Weight gain', frequency: 'common' },
      { effect: 'Sexual dysfunction', frequency: 'common' },
      { effect: 'Anticholinergic effects', frequency: 'common' },
      { effect: 'Discontinuation syndrome', frequency: 'common' },
    ],
    cautions: {
      other: ['Glaucoma', 'BPH', 'Cognitive impairment'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: '14-day washout' },
      { drug: 'Tamoxifen', severity: 'contraindicated', mechanism: 'Inhibits CYP2D6, reduces tamoxifen efficacy', recommendation: 'Use alternative SSRI' },
    ],
    clinicalPearls: [
      'Avoid in patients with glaucoma or cognitive concerns',
      'NOT recommended in tamoxifen users (breast cancer)',
      'Most anticholinergic SSRI',
      'Best evidence for hot flashes',
    ],
    monitoring: [
      { parameter: 'Weight', baseline: true, followUp: 'Monitor monthly', frequency: 'Monthly x 3, then quarterly' },
    ],
    pregnancyCategory: 'D',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'citalopram',
    name: 'Citalopram',
    genericName: 'Celexa',
    tags: ['SSRI', 'Antidepressant'],
    class: 'SSRI',
    indications: ['Major Depressive Disorder'],
    quickFlags: ['QT-caution', 'Weight-neutral'],
    dosing: {
      adult: {
        start: '20 mg/day',
        titration: 'May increase to 40 mg after 1 week',
        maintenance: '20-40 mg/day',
        max: '40 mg/day (20 mg if >60 years)',
      },
      geriatric: {
        start: '10 mg/day',
        maintenance: '10-20 mg/day',
        notes: 'Do not exceed 20 mg/day due to QT risk',
      },
      hepatic: 'Max 20 mg/day',
      notes: 'FDA black box warning on QT prolongation',
    },
    warnings: [
      'QT prolongation - max 40 mg (20 mg if >60 years)',
      'Avoid in congenital long QT syndrome',
    ],
    sideEffects: [
      { effect: 'QT prolongation', frequency: 'uncommon' },
      { effect: 'Nausea', frequency: 'common' },
      { effect: 'Somnolence', frequency: 'common' },
    ],
    interactions: [
      { drug: 'QT prolonging drugs', severity: 'major', mechanism: 'Additive QT effect', recommendation: 'Avoid combination' },
    ],
    clinicalPearls: [
      'Escitalopram is the active enantiomer - generally preferred',
      'QT concerns limit dosing',
    ],
    qtRisk: 'moderate',
    citations: ['FDA Warning 2011'],
    updatedAt: '2024-01-15',
  },
  // SNRIs
  {
    id: 'venlafaxine',
    name: 'Venlafaxine XR',
    genericName: 'Effexor XR',
    tags: ['SNRI', 'Antidepressant', 'Second-line'],
    class: 'SNRI',
    indications: ['Major Depressive Disorder', 'GAD', 'Panic Disorder', 'Social Anxiety Disorder'],
    quickFlags: ['Second-line', 'QT-safe', 'Activating'],
    dosing: {
      adult: {
        start: '37.5-75 mg/day',
        titration: 'Increase by 75 mg every 4 days',
        maintenance: '75-225 mg/day',
        max: '375 mg/day (225 mg for anxiety)',
      },
      geriatric: {
        start: '37.5 mg/day',
        maintenance: '75-150 mg/day',
        notes: 'Monitor blood pressure',
      },
      renal: 'Reduce dose by 25-50%',
      hepatic: 'Reduce dose by 50%',
      notes: 'Take with food. XR formulation preferred.',
    },
    warnings: [
      'Discontinuation syndrome can be severe - taper slowly',
      'Blood pressure elevation at higher doses',
      'Serotonin syndrome risk',
    ],
    sideEffects: [
      { effect: 'Nausea', frequency: 'very-common', management: 'Take with food' },
      { effect: 'Hypertension', frequency: 'common', management: 'Monitor BP at doses >150mg' },
      { effect: 'Insomnia', frequency: 'common' },
      { effect: 'Sweating', frequency: 'common' },
      { effect: 'Discontinuation syndrome', frequency: 'common' },
    ],
    cautions: {
      cardiac: 'Monitor BP, may cause dose-dependent HTN',
      other: ['Renal impairment requires dose reduction'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: '14-day washout' },
      { drug: 'NSAIDs', severity: 'moderate', mechanism: 'Bleeding risk', recommendation: 'Monitor or use PPI' },
    ],
    clinicalPearls: [
      'May have higher remission rates than SSRIs at higher doses (>150mg)',
      'Useful when SSRIs fail - dual mechanism at higher doses',
      'Severe discontinuation - taper over weeks to months',
      'Monitor BP at 150mg+',
    ],
    monitoring: [
      { parameter: 'Blood Pressure', baseline: true, followUp: 'Check at each dose increase', frequency: 'At doses >150mg' },
      { parameter: 'PHQ-9', baseline: true, followUp: 'Every 2-4 weeks', frequency: 'Until stable' },
    ],
    equivalents: [
      { fromDrug: 'Desvenlafaxine 50mg', fromDose: '50 mg', toDose: '75 mg' },
      { fromDrug: 'Duloxetine 60mg', fromDose: '60 mg', toDose: '75 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'duloxetine',
    name: 'Duloxetine',
    genericName: 'Cymbalta',
    tags: ['SNRI', 'Antidepressant', 'Pain indication'],
    class: 'SNRI',
    indications: ['Major Depressive Disorder', 'GAD', 'Diabetic Peripheral Neuropathic Pain', 'Fibromyalgia', 'Chronic Musculoskeletal Pain'],
    quickFlags: ['QT-safe', 'Weight-neutral'],
    dosing: {
      adult: {
        start: '30-60 mg/day',
        titration: 'May increase to 60 mg after 1 week',
        maintenance: '60 mg/day (40-60 mg for pain)',
        max: '120 mg/day',
      },
      geriatric: {
        start: '30 mg/day',
        maintenance: '30-60 mg/day',
        notes: 'Start low to minimize nausea',
      },
      renal: 'Avoid in severe renal impairment (CrCl <30)',
      hepatic: 'Avoid in hepatic impairment',
      notes: 'May take with or without food',
    },
    warnings: [
      'Avoid in severe renal/hepatic impairment',
      'Monitor for hepatotoxicity',
      'May increase bleeding risk',
    ],
    sideEffects: [
      { effect: 'Nausea', frequency: 'very-common', management: 'Start 30mg, take with food' },
      { effect: 'Dry mouth', frequency: 'common' },
      { effect: 'Constipation', frequency: 'common' },
      { effect: 'Fatigue', frequency: 'common' },
    ],
    cautions: {
      hepatic: 'Contraindicated in liver disease',
      renal: 'Avoid if CrCl <30',
      other: ['Alcohol use', 'Chronic liver disease'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: '14-day washout' },
      { drug: 'CYP1A2 inhibitors', severity: 'moderate', mechanism: 'May increase duloxetine levels', recommendation: 'Monitor or adjust dose' },
    ],
    clinicalPearls: [
      'Preferred when depression co-occurs with pain conditions',
      'No dose adjustment needed for mild-moderate renal impairment',
      'Useful for patients with depression + fibromyalgia/DM neuropathy',
    ],
    monitoring: [
      { parameter: 'Liver enzymes', baseline: true, followUp: 'If symptoms of hepatotoxicity', frequency: 'As clinically indicated' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  // Atypical Antidepressants
  {
    id: 'bupropion',
    name: 'Bupropion XL',
    genericName: 'Wellbutrin XL / Zyban',
    tags: ['NDRI', 'Antidepressant', 'Activating', 'No sexual side effects'],
    class: 'Atypical Antidepressant',
    indications: ['Major Depressive Disorder', 'Seasonal Affective Disorder', 'Smoking Cessation'],
    quickFlags: ['Second-line', 'Weight-loss', 'QT-safe', 'Activating'],
    dosing: {
      adult: {
        start: '150 mg XL morning',
        titration: 'Increase to 300 mg after 1 week',
        maintenance: '150-450 mg/day (XL)',
        max: '450 mg/day',
      },
      geriatric: {
        start: '100 mg SR twice daily or 150 mg XL',
        maintenance: '150-300 mg/day',
        notes: 'Increased seizure risk in elderly',
      },
      hepatic: 'Reduce dose/frequency',
      notes: 'Morning dosing only (insomnia risk). Never take after 5pm.',
    },
    warnings: [
      'Contraindicated in seizure disorders, bulimia, anorexia (lowers seizure threshold)',
      'Contraindicated in abrupt alcohol/benzodiazepine discontinuation',
      'Avoid if history of head trauma',
      'Can increase anxiety initially',
    ],
    sideEffects: [
      { effect: 'Insomnia', frequency: 'very-common', management: 'Morning dosing only' },
      { effect: 'Dry mouth', frequency: 'common' },
      { effect: 'Headache', frequency: 'common' },
      { effect: 'Anxiety/Activation', frequency: 'common', management: 'Start low, increase slowly' },
      { effect: 'Tremor', frequency: 'common' },
    ],
    cautions: {
      seizure: 'Contraindicated - significantly lowers seizure threshold',
      other: ['Eating disorders', 'Alcohol withdrawal', 'Bipolar disorder (may induce mania)'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Hypertensive crisis', recommendation: 'Wait 14 days' },
      { drug: 'Alcohol', severity: 'major', mechanism: 'Increased seizure risk', recommendation: 'Limit or avoid' },
    ],
    clinicalPearls: [
      'No sexual side effects - good for SSRI-induced sexual dysfunction',
      'May cause weight loss - useful in overweight patients',
      'Activating - good for fatigue/hypersomnia',
      'Avoid in anxiety disorders (can worsen)',
      'Useful for smoking cessation (Zyban)',
    ],
    monitoring: [
      { parameter: 'Seizure symptoms', baseline: true, followUp: 'Counsel on seizure risk', frequency: 'At initiation' },
      { parameter: 'Blood pressure', baseline: true, followUp: 'Monitor periodically', frequency: 'Every 3-6 months' },
    ],
    equivalents: [
      { fromDrug: 'Bupropion SR 100mg BID', fromDose: '200 mg/day SR', toDose: '150 mg XL' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'mirtazapine',
    name: 'Mirtazapine',
    genericName: 'Remeron',
    tags: ['NaSSA', 'Antidepressant', 'Sedating', 'Appetite stimulant'],
    class: 'Atypical Antidepressant',
    indications: ['Major Depressive Disorder', 'Insomnia associated with depression', 'Appetite loss/weight loss'],
    quickFlags: ['Second-line', 'Weight-gain', 'QT-safe', 'Sedating'],
    dosing: {
      adult: {
        start: '15 mg at bedtime',
        titration: 'Increase by 15 mg every 1-2 weeks',
        maintenance: '15-45 mg/day',
        max: '45 mg/day',
      },
      geriatric: {
        start: '7.5 mg at bedtime',
        maintenance: '15-30 mg/day',
        notes: 'Monitor for confusion, dizziness',
      },
      renal: 'No adjustment',
      hepatic: 'Use with caution',
      notes: 'Take at bedtime. Lower doses more sedating (antihistamine effect).',
    },
    warnings: [
      'Significant weight gain',
      'Sedation (paradoxically less at higher doses)',
      'Agranulocytosis (rare but serious)',
    ],
    sideEffects: [
      { effect: 'Weight gain', frequency: 'very-common', management: 'Dietary counseling' },
      { effect: 'Sedation', frequency: 'very-common', management: 'Lower doses more sedating' },
      { effect: 'Increased appetite', frequency: 'very-common' },
      { effect: 'Dry mouth', frequency: 'common' },
      { effect: 'Constipation', frequency: 'common' },
    ],
    cautions: {
      other: ['Diabetes', 'Hyperlipidemia', 'Elderly fall risk'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: 'Wait 14 days' },
      { drug: 'Alcohol', severity: 'moderate', mechanism: 'Additive sedation', recommendation: 'Avoid' },
    ],
    clinicalPearls: [
      'Paradoxical dosing: 7.5-15mg most sedating, 30-45mg less sedating',
      'Excellent for depression with insomnia and poor appetite',
      'No sexual side effects',
      'May help nausea/vomiting',
      'Monitor WBC if fever/sore throat',
    ],
    monitoring: [
      { parameter: 'Weight', baseline: true, followUp: 'Monitor closely', frequency: 'Weekly x 4, then monthly' },
      { parameter: 'Lipids', baseline: true, followUp: 'Check if significant weight gain', frequency: 'Every 3-6 months' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Depression 2016'],
    updatedAt: '2024-01-15',
  },
  // Atypical Antipsychotics
  {
    id: 'quetiapine',
    name: 'Quetiapine',
    genericName: 'Seroquel',
    tags: ['Atypical Antipsychotic', 'Bipolar', 'Insomnia', 'Second-line depression'],
    class: 'Atypical Antipsychotic',
    indications: ['Schizophrenia', 'Bipolar Disorder (mania/depression)', 'Bipolar Depression', 'Major Depression (adjunct)', 'Insomnia (off-label)'],
    quickFlags: ['Second-line', 'Sedating', 'Weight-gain', 'QT-caution'],
    dosing: {
      adult: {
        start: '25-50 mg BID (psychosis), 50 mg at bedtime (depression)',
        titration: 'Increase by 50-100 mg every 1-2 days',
        maintenance: '400-800 mg/day (psychosis), 300 mg/day (bipolar depression)',
        max: '800 mg/day',
      },
      geriatric: {
        start: '25 mg/day',
        maintenance: '100-200 mg/day',
        notes: 'Start very low, monitor for orthostatic hypotension',
      },
      hepatic: 'Start 25 mg/day, increase slowly',
      notes: 'IR: BID dosing preferred; XR: Once daily evening',
    },
    warnings: [
      'Metabolic syndrome - monitor weight, glucose, lipids',
      'QT prolongation',
      'Orthostatic hypotension, especially in elderly',
      'Sedation and cognitive impairment',
    ],
    sideEffects: [
      { effect: 'Sedation', frequency: 'very-common', management: 'Bedtime dosing, titrate slowly' },
      { effect: 'Weight gain', frequency: 'very-common', management: 'Diet/exercise counseling' },
      { effect: 'Dry mouth', frequency: 'common' },
      { effect: 'Constipation', frequency: 'common' },
      { effect: 'Orthostatic hypotension', frequency: 'common' },
    ],
    cautions: {
      cardiac: 'QT prolongation, orthostatic hypotension',
      hepatic: 'Reduce dose',
      other: ['Diabetes', 'Cataracts (annual eye exam)', 'Elderly fall risk'],
    },
    interactions: [
      { drug: 'QT prolonging drugs', severity: 'major', mechanism: 'Additive QT effect', recommendation: 'Avoid or monitor ECG' },
      { drug: 'CYP3A4 inducers (carbamazepine)', severity: 'major', mechanism: 'Decreased quetiapine levels', recommendation: 'May need dose increase' },
      { drug: 'CYP3A4 inhibitors', severity: 'moderate', mechanism: 'Increased quetiapine levels', recommendation: 'May need dose reduction' },
    ],
    clinicalPearls: [
      'Most sedating atypical antipsychotic',
      'FDA approved for bipolar depression (300mg) and as adjunct for MDD',
      'Lowest EPS risk among atypicals',
      'Monitor metabolic parameters closely',
      'Not first-line for psychosis due to metabolic effects',
    ],
    monitoring: [
      { parameter: 'Weight/BMI', baseline: true, followUp: 'Monitor monthly x 3, then quarterly', frequency: 'Quarterly' },
      { parameter: 'Fasting glucose/HbA1c', baseline: true, followUp: 'At 3 months, then annually', frequency: 'Annually' },
      { parameter: 'Lipid panel', baseline: true, followUp: 'At 3 months, then annually', frequency: 'Annually' },
      { parameter: 'ECG', baseline: false, followUp: 'If cardiac risk or on other QT drugs', frequency: 'As needed' },
    ],
    equivalents: [
      { fromDrug: 'Olanzapine 10mg', fromDose: '10 mg', toDose: '200 mg' },
      { fromDrug: 'Risperidone 2mg', fromDose: '2 mg', toDose: '100 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'moderate',
    citations: ['CANMAT Bipolar 2018'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'aripiprazole',
    name: 'Aripiprazole',
    genericName: 'Abilify',
    tags: ['Atypical Antipsychotic', 'Partial agonist', 'First-line augmentation'],
    class: 'Atypical Antipsychotic',
    indications: ['Schizophrenia', 'Bipolar Disorder (mania/maintenance)', 'Major Depression (adjunct)', 'Autism (irritability)', 'Tourette Syndrome'],
    quickFlags: ['First-line', 'Weight-neutral', 'QT-safe', 'Activating'],
    dosing: {
      adult: {
        start: '10-15 mg/day',
        titration: 'May increase to 30 mg/day',
        maintenance: '10-30 mg/day (psychosis), 2-15 mg/day (adjunct for MDD)',
        max: '30 mg/day',
      },
      geriatric: {
        start: '2-5 mg/day',
        maintenance: '5-15 mg/day',
        notes: 'Start low, monitor for akathisia',
      },
      hepatic: 'No adjustment needed',
      notes: 'May take with or without food. Long-acting injectable available.',
    },
    warnings: [
      'Akathisia (most common side effect)',
      'May cause activation/anxiety',
      'Impulse control disorders (gambling, shopping, hypersexuality)',
    ],
    sideEffects: [
      { effect: 'Akathisia', frequency: 'very-common', management: 'Reduce dose, add propranolol or benztropine' },
      { effect: 'Insomnia', frequency: 'common' },
      { effect: 'Anxiety/Activation', frequency: 'common', management: 'Morning dosing' },
      { effect: 'Headache', frequency: 'common' },
      { effect: 'Nausea', frequency: 'common' },
    ],
    cautions: {
      other: ['Cerebrovascular disease in elderly', 'Impulse control disorders'],
    },
    interactions: [
      { drug: 'CYP2D6 inhibitors', severity: 'moderate', mechanism: 'Increased aripiprazole levels', recommendation: 'Reduce aripiprazole dose by 50%' },
      { drug: 'CYP3A4 inhibitors', severity: 'moderate', mechanism: 'Increased aripiprazole levels', recommendation: 'Reduce dose' },
      { drug: 'CYP3A4 inducers', severity: 'moderate', mechanism: 'Decreased levels', recommendation: 'Double dose' },
    ],
    clinicalPearls: [
      'Partial dopamine agonist - unique mechanism',
      'First-line for augmentation in treatment-resistant depression',
      'Most weight-neutral antipsychotic',
      'Low metabolic side effects compared to other atypicals',
      'Monitor for impulse control disorders',
    ],
    monitoring: [
      { parameter: 'Weight/metabolic', baseline: true, followUp: 'Monitor less frequently than other atypicals', frequency: 'Every 6 months' },
      { parameter: 'Akathisia', baseline: true, followUp: 'Assess at each visit', frequency: 'Every visit x 4 weeks' },
    ],
    equivalents: [
      { fromDrug: 'Risperidone 2mg', fromDose: '2 mg', toDose: '10 mg' },
      { fromDrug: 'Olanzapine 10mg', fromDose: '10 mg', toDose: '15 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Bipolar 2018'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'olanzapine',
    name: 'Olanzapine',
    genericName: 'Zyprexa',
    tags: ['Atypical Antipsychotic', 'High metabolic risk'],
    class: 'Atypical Antipsychotic',
    indications: ['Schizophrenia', 'Bipolar Disorder (mania/maintenance)', 'Treatment-resistant Depression (with fluoxetine - Symbyax)'],
    quickFlags: ['Second-line', 'Sedating', 'Weight-gain', 'QT-safe'],
    dosing: {
      adult: {
        start: '5-10 mg/day',
        titration: 'Increase by 5 mg every week',
        maintenance: '10-20 mg/day',
        max: '20 mg/day',
      },
      geriatric: {
        start: '2.5-5 mg/day',
        maintenance: '5-10 mg/day',
        notes: 'Increased risk of orthostatic hypotension and falls',
      },
      hepatic: 'Start 5 mg/day',
      notes: 'Take without regard to food',
    },
    warnings: [
      'Highest metabolic risk of all antipsychotics',
      'Significant weight gain and diabetes risk',
      'Sedation and cognitive impairment',
    ],
    sideEffects: [
      { effect: 'Weight gain', frequency: 'very-common', management: 'Aggressive monitoring and lifestyle intervention' },
      { effect: 'Sedation', frequency: 'very-common' },
      { effect: 'Metabolic effects', frequency: 'very-common' },
      { effect: 'Dry mouth', frequency: 'common' },
      { effect: 'Constipation', frequency: 'common' },
    ],
    cautions: {
      other: ['Diabetes', 'Hyperlipidemia', 'Obesity', 'Cognitive impairment'],
    },
    interactions: [
      { drug: 'CYP1A2 inducers (smoking)', severity: 'major', mechanism: 'Decreased olanzapine levels', recommendation: 'May need dose increase in smokers' },
      { drug: 'CYP1A2 inhibitors', severity: 'moderate', mechanism: 'Increased levels', recommendation: 'May need dose reduction' },
    ],
    clinicalPearls: [
      'Highest weight gain and metabolic risk - monitor aggressively',
      'Very effective for mania and psychosis',
      'Smoking induces metabolism - may need higher doses',
      'Long-acting injectable available',
    ],
    monitoring: [
      { parameter: 'Weight/BMI', baseline: true, followUp: 'Monthly x 3, then quarterly', frequency: 'Quarterly' },
      { parameter: 'Fasting glucose/HbA1c', baseline: true, followUp: 'At 3 months, then every 6 months', frequency: 'Every 6 months' },
      { parameter: 'Lipid panel', baseline: true, followUp: 'At 3 months, then every 6 months', frequency: 'Every 6 months' },
    ],
    equivalents: [
      { fromDrug: 'Risperidone 2mg', fromDose: '2 mg', toDose: '5 mg' },
      { fromDrug: 'Haloperidol 5mg', fromDose: '5 mg', toDose: '10 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Bipolar 2018'],
    updatedAt: '2024-01-15',
  },
  // Mood Stabilizers
  {
    id: 'lithium',
    name: 'Lithium Carbonate',
    genericName: 'Carbolith / Eskalith',
    tags: ['Mood Stabilizer', 'First-line bipolar', 'Gold standard'],
    class: 'Mood Stabilizer',
    indications: ['Bipolar Disorder (mania, maintenance)', 'Major Depression (augmentation)', 'Suicide prevention'],
    quickFlags: ['First-line', 'Weight-gain', 'QT-safe', 'Renal monitoring'],
    dosing: {
      adult: {
        start: '300 mg BID-TID or 600 mg HS (extended release)',
        titration: 'Increase by 300 mg every 3-5 days based on levels',
        maintenance: '900-1800 mg/day (acute), 600-1200 mg/day (maintenance)',
        max: 'Based on serum levels (1.2 mEq/L acute, 0.6-0.8 mEq/L maintenance)',
      },
      geriatric: {
        start: '150-300 mg/day',
        maintenance: '300-600 mg/day',
        notes: 'Target lower levels (0.4-0.6 mEq/L)',
      },
      renal: 'Contraindicated if CrCl <30 mL/min',
      notes: 'Take with food. Maintain consistent salt and fluid intake.',
    },
    warnings: [
      'Narrow therapeutic window - monitor levels',
      'Renal toxicity with long-term use',
      'Hypothyroidism',
      'Teratogenic - avoid in pregnancy (Ebstein anomaly)',
      'Toxicity symptoms: vomiting, diarrhea, ataxia, confusion',
    ],
    sideEffects: [
      { effect: 'Tremor', frequency: 'common', management: 'Beta-blockers, reduce dose' },
      { effect: 'Polyuria/polydipsia', frequency: 'common', management: 'Check renal function' },
      { effect: 'Weight gain', frequency: 'common' },
      { effect: 'Hypothyroidism', frequency: 'common', management: 'Thyroid replacement' },
      { effect: 'Nausea/diarrhea', frequency: 'common', management: 'Take with food, consider extended release' },
    ],
    cautions: {
      renal: 'Contraindicated in significant renal impairment',
      cardiac: 'AV block, sick sinus syndrome',
      other: ['Dehydration', 'Low sodium diets', 'NSAIDs', 'ACE inhibitors', 'Diuretics'],
    },
    interactions: [
      { drug: 'ACE inhibitors/ARBs', severity: 'major', mechanism: 'Increased lithium levels', recommendation: 'Avoid or monitor levels closely' },
      { drug: 'Diuretics', severity: 'major', mechanism: 'Increased lithium levels', recommendation: 'Avoid thiazides, monitor closely' },
      { drug: 'NSAIDs', severity: 'major', mechanism: 'Increased lithium levels', recommendation: 'Avoid or monitor levels' },
      { drug: 'Antipsychotics', severity: 'moderate', mechanism: 'Increased neuroleptic malignant syndrome risk', recommendation: 'Monitor for NMS symptoms' },
    ],
    clinicalPearls: [
      'Gold standard for bipolar disorder - superior for suicide prevention',
      'Best evidence for maintenance treatment',
      'Requires regular monitoring but highly effective',
      'Low doses effective for depression augmentation',
      'Maintain adequate hydration and consistent sodium intake',
    ],
    monitoring: [
      { parameter: 'Serum lithium level', baseline: false, followUp: 'Check 5 days after dose change', frequency: 'Every 3-6 months when stable' },
      { parameter: 'CBC', baseline: true, followUp: 'Monitor for leukocytosis', frequency: 'Every 6-12 months' },
      { parameter: 'TSH', baseline: true, followUp: 'Every 6 months', frequency: 'Every 6 months' },
      { parameter: 'Creatinine/eGFR', baseline: true, followUp: 'Every 3 months x 1 year, then every 6 months', frequency: 'Every 6 months' },
      { parameter: 'Electrolytes', baseline: true, followUp: 'Monitor sodium', frequency: 'Every 3-6 months' },
      { parameter: 'ECG', baseline: true, followUp: 'If cardiac symptoms', frequency: 'As needed' },
      { parameter: 'Weight', baseline: true, followUp: 'Monitor for gain', frequency: 'Every 3 months' },
    ],
    pregnancyCategory: 'D',
    qtRisk: 'none',
    citations: ['CANMAT Bipolar 2018'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'lamotrigine',
    name: 'Lamotrigine',
    genericName: 'Lamictal',
    tags: ['Mood Stabilizer', 'Anticonvulsant', 'Bipolar depression'],
    class: 'Mood Stabilizer',
    indications: ['Bipolar Disorder (maintenance, depression)', 'Bipolar Depression', 'Epilepsy'],
    quickFlags: ['First-line', 'Weight-neutral', 'QT-safe', 'Slow titration'],
    dosing: {
      adult: {
        start: '25 mg/day (weeks 1-2), 50 mg/day (weeks 3-4)',
        titration: 'Increase by 50 mg every 1-2 weeks',
        maintenance: '200 mg/day (100-400 mg/day)',
        max: '500 mg/day (alone), 200 mg/day (with valproate), 400 mg/day (with enzyme inducers)',
      },
      notes: 'SLOW TITRATION ESSENTIAL to prevent rash.',
    },
    warnings: [
      'SERIOUS RASH (SJS/TEN) - slow titration required',
      'Benign rashes common but must differentiate from serious rash',
      'Discontinue if rash develops (unless clearly not drug-related)',
    ],
    sideEffects: [
      { effect: 'Headache', frequency: 'common' },
      { effect: 'Insomnia', frequency: 'common' },
      { effect: 'Nausea', frequency: 'common' },
      { effect: 'Rash', frequency: 'common', management: 'STOP drug, seek medical attention' },
    ],
    cautions: {
      other: ['History of rash with other drugs', 'Concurrent valproate (reduces dose needed)'],
    },
    interactions: [
      { drug: 'Valproate', severity: 'major', mechanism: 'Inhibits metabolism - doubles lamotrigine levels', recommendation: 'Reduce lamotrigine dose by 50%' },
      { drug: 'Carbamazepine', severity: 'major', mechanism: 'Induces metabolism - halves lamotrigine levels', recommendation: 'May need to double lamotrigine dose' },
      { drug: 'Oral contraceptives', severity: 'moderate', mechanism: 'Reduces lamotrigine levels by 50%', recommendation: 'Adjust dose; monitor during pill-free week' },
      { drug: 'Estrogen', severity: 'moderate', mechanism: 'Reduces lamotrigine levels', recommendation: 'May need dose adjustment' },
    ],
    clinicalPearls: [
      'Best evidence for bipolar depression maintenance',
      'Not effective for acute mania',
      'Weight-neutral',
      'Slow titration mandatory - rash risk if titrated too fast',
      'Drug interactions significant - adjust dose with valproate/carbamazepine',
      'Oral contraceptives reduce levels - may need dose adjustment',
    ],
    titrationSchedule: [
      { week: 1, dose: '25 mg/day', notes: 'Start low' },
      { week: 2, dose: '25 mg/day', notes: 'Continue 25mg' },
      { week: 3, dose: '50 mg/day', notes: 'Increase to 50mg' },
      { week: 4, dose: '50 mg/day', notes: 'Continue 50mg' },
      { week: 5, dose: '100 mg/day', notes: 'Increase by 50mg' },
      { week: 6, dose: '150 mg/day', notes: 'Increase by 50mg' },
      { week: 7, dose: '200 mg/day', notes: 'Target maintenance dose' },
    ],
    monitoring: [
      { parameter: 'Rash check', baseline: true, followUp: 'Counsel patient to report any rash immediately', frequency: 'At each visit' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT Bipolar 2018'],
    updatedAt: '2024-01-15',
  },
  // Benzodiazepines
  {
    id: 'lorazepam',
    name: 'Lorazepam',
    genericName: 'Ativan',
    tags: ['Benzodiazepine', 'Anxiolytic', 'Sedative', 'Alcohol withdrawal'],
    class: 'Benzodiazepine',
    indications: ['Anxiety Disorders', 'Insomnia', 'Acute Agitation', 'Alcohol Withdrawal', 'Seizures', 'Preoperative sedation'],
    quickFlags: ['QT-safe', 'Sedating'],
    dosing: {
      adult: {
        start: '0.5-2 mg PO/IM/IV',
        titration: 'As needed for symptoms',
        maintenance: '1-6 mg/day divided doses (anxiety), 2-4 mg at bedtime (insomnia)',
        max: '10 mg/day',
      },
      geriatric: {
        start: '0.25-0.5 mg',
        maintenance: '0.5-2 mg/day',
        notes: 'Increased sensitivity, fall risk, cognitive impairment',
      },
      hepatic: 'Preferred in hepatic impairment (no active metabolites)',
      notes: 'IV: Onset 5 min, Peak 30-60 min, Duration 6-8 hrs. PO: Onset 30-60 min.',
    },
    warnings: [
      'Dependence and withdrawal with long-term use',
      'Respiratory depression - caution with opioids/alcohol',
      'Fall risk in elderly',
      'Cognitive impairment',
      'Paradoxical reactions (agitation)',
    ],
    sideEffects: [
      { effect: 'Sedation', frequency: 'very-common' },
      { effect: 'Dizziness', frequency: 'common' },
      { effect: 'Ataxia', frequency: 'common' },
      { effect: 'Confusion (elderly)', frequency: 'common' },
      { effect: 'Respiratory depression', frequency: 'uncommon' },
    ],
    cautions: {
      other: ['Respiratory disorders', 'Sleep apnea', 'Myasthenia gravis', 'Substance use disorder'],
    },
    interactions: [
      { drug: 'Opioids', severity: 'contraindicated', mechanism: 'Profound respiratory depression', recommendation: 'Avoid concurrent use if possible' },
      { drug: 'Alcohol', severity: 'major', mechanism: 'Additive CNS depression', recommendation: 'Avoid' },
      { drug: 'Other CNS depressants', severity: 'major', mechanism: 'Additive sedation', recommendation: 'Use with caution' },
    ],
    clinicalPearls: [
      'Preferred benzodiazepine in hepatic impairment (no active metabolites)',
      'CIWA-Ar for alcohol withdrawal - commonly used',
      'Short-term use only for anxiety (2-4 weeks)',
      'Taper slowly to avoid withdrawal (reduce by 25% every 2 weeks)',
      'Use lowest effective dose for shortest duration',
    ],
    equivalents: [
      { fromDrug: 'Diazepam 5mg', fromDose: '5 mg', toDose: '1 mg' },
      { fromDrug: 'Clonazepam 0.5mg', fromDose: '0.5 mg', toDose: '1 mg' },
      { fromDrug: 'Alprazolam 0.5mg', fromDose: '0.5 mg', toDose: '1 mg' },
    ],
    pregnancyCategory: 'D',
    qtRisk: 'none',
    citations: ['CIWA-Ar Protocol'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'clonazepam',
    name: 'Clonazepam',
    genericName: 'Klonopin / Rivotril',
    tags: ['Benzodiazepine', 'Long-acting', 'Anticonvulsant', 'Anxiolytic'],
    class: 'Benzodiazepine',
    indications: ['Panic Disorder', 'Seizure Disorders', 'Akathisia', 'Acute Mania (adjunct)', 'REM Sleep Behavior Disorder'],
    quickFlags: ['QT-safe', 'Sedating'],
    dosing: {
      adult: {
        start: '0.25 mg BID (panic), 0.5 mg TID (seizures)',
        titration: 'Increase by 0.25-0.5 mg every 3 days',
        maintenance: '1-4 mg/day (panic), 1.5-20 mg/day (seizures)',
        max: '4 mg/day (panic), 20 mg/day (seizures)',
      },
      geriatric: {
        start: '0.125-0.25 mg/day',
        maintenance: '0.5-2 mg/day',
        notes: 'Increased fall and cognitive risk',
      },
      hepatic: 'Use with caution',
      notes: 'Long half-life (30-40 hrs) - useful for maintenance, problematic for accumulation',
    },
    warnings: [
      'Long half-life - accumulation risk, especially in elderly',
      'Dependence and withdrawal',
      'Respiratory depression',
    ],
    sideEffects: [
      { effect: 'Sedation', frequency: 'very-common' },
      { effect: 'Cognitive impairment', frequency: 'common' },
      { effect: 'Ataxia', frequency: 'common' },
      { effect: 'Depression', frequency: 'common' },
    ],
    interactions: [
      { drug: 'Opioids', severity: 'contraindicated', mechanism: 'Respiratory depression', recommendation: 'Avoid' },
      { drug: 'CYP3A4 inhibitors', severity: 'moderate', mechanism: 'Increased clonazepam levels', recommendation: 'May need dose reduction' },
    ],
    clinicalPearls: [
      'Long half-life allows less frequent dosing',
      'Accumulates - not ideal for PRN use',
      'Effective for panic disorder',
      'Commonly used for akathisia',
      'Taper slowly due to long half-life',
    ],
    equivalents: [
      { fromDrug: 'Lorazepam 1mg', fromDose: '1 mg', toDose: '0.25 mg' },
      { fromDrug: 'Diazepam 5mg', fromDose: '5 mg', toDose: '0.25 mg' },
    ],
    pregnancyCategory: 'D',
    qtRisk: 'none',
    citations: ['CANMAT Anxiety 2014'],
    updatedAt: '2024-01-15',
  },
  // Stimulants
  {
    id: 'methylphenidate',
    name: 'Methylphenidate',
    genericName: 'Ritalin / Concerta',
    tags: ['Stimulant', 'ADHD', 'Narcolepsy'],
    class: 'Stimulant',
    indications: ['ADHD', 'Narcolepsy', 'Treatment-resistant Depression (off-label)'],
    quickFlags: ['QT-safe', 'Activating', 'Appetite suppressant'],
    dosing: {
      adult: {
        start: '5-10 mg BID-TID (immediate), 18-36 mg/day (Concerta)',
        titration: 'Increase by 5-10 mg per dose every week',
        maintenance: '20-60 mg/day (divided doses IR), 18-72 mg/day (Concerta)',
        max: '60 mg/day (IR), 72 mg/day (Concerta)',
      },
      geriatric: {
        start: '2.5-5 mg/day',
        maintenance: '5-20 mg/day',
        notes: 'Start low, monitor cardiovascular effects',
      },
      hepatic: 'No adjustment needed',
      notes: 'IR: Lasts 3-4 hrs. SR: Lasts 4-6 hrs. LA/XR: Lasts 8-12 hrs.',
    },
    warnings: [
      'Abuse and dependence potential',
      'Cardiovascular effects - monitor BP/HR',
      'Growth suppression in children',
      'Psychiatric effects - may worsen psychosis, mania',
      'Contraindicated in glaucoma',
    ],
    sideEffects: [
      { effect: 'Insomnia', frequency: 'very-common', management: 'Morning dosing, avoid late doses' },
      { effect: 'Appetite suppression', frequency: 'very-common', management: 'Meals before dosing, high-calorie snacks' },
      { effect: 'Headache', frequency: 'common' },
      { effect: 'Increased BP/HR', frequency: 'common', management: 'Monitor cardiovascular parameters' },
      { effect: 'Irritability', frequency: 'common' },
    ],
    cautions: {
      cardiac: 'Hypertension, arrhythmias, structural heart disease',
      other: ['Glaucoma', 'Anxiety disorders', 'Bipolar disorder', 'Substance use disorder', 'Tics'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Hypertensive crisis', recommendation: 'Wait 14 days after MAOI' },
      { drug: 'Antihypertensives', severity: 'moderate', mechanism: 'Reduced efficacy of antihypertensives', recommendation: 'Monitor BP' },
    ],
    clinicalPearls: [
      'First-line for ADHD',
      'Multiple formulations available - match to patient needs',
      'Drug holidays may help with growth/appetite concerns',
      'Monitor for diversion/misuse',
      'May worsen anxiety or bipolar disorder',
    ],
    monitoring: [
      { parameter: 'BP and Pulse', baseline: true, followUp: 'At each visit', frequency: 'Every visit' },
      { parameter: 'Weight', baseline: true, followUp: 'Monitor for loss', frequency: 'Monthly' },
      { parameter: 'Sleep', baseline: true, followUp: 'Assess sleep quality', frequency: 'Every visit' },
      { parameter: 'ADHD symptoms', baseline: true, followUp: 'Use rating scales', frequency: 'Monthly x 3, then every 3 months' },
    ],
    equivalents: [
      { fromDrug: 'Amphetamine mixed salts 10mg', fromDose: '10 mg', toDose: '20 mg' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['CANMAT ADHD 2018'],
    updatedAt: '2024-01-15',
  },
  // Sleep aids
  {
    id: 'trazodone',
    name: 'Trazodone',
    genericName: 'Desyrel',
    tags: ['SARI', 'Antidepressant', 'Sleep aid'],
    class: 'Atypical Antidepressant',
    indications: ['Insomnia', 'Major Depressive Disorder (rarely used as monotherapy)'],
    quickFlags: ['QT-safe', 'Sedating', 'Weight-neutral'],
    dosing: {
      adult: {
        start: '25-50 mg at bedtime (insomnia), 150 mg/day (depression)',
        titration: 'May increase by 50 mg every 3-4 days',
        maintenance: '50-100 mg at bedtime (insomnia), 150-400 mg/day (depression)',
        max: '400 mg/day (outpatient), 600 mg/day (inpatient)',
      },
      geriatric: {
        start: '25 mg at bedtime',
        maintenance: '25-100 mg at bedtime',
        notes: 'Start low to minimize orthostatic hypotension',
      },
      notes: 'Take at bedtime due to sedation',
    },
    warnings: [
      'Priapism (rare but serious emergency)',
      'Orthostatic hypotension',
      'Sedation',
    ],
    sideEffects: [
      { effect: 'Sedation', frequency: 'very-common' },
      { effect: 'Orthostatic hypotension', frequency: 'common' },
      { effect: 'Dry mouth', frequency: 'common' },
      { effect: 'Dizziness', frequency: 'common' },
      { effect: 'Priapism', frequency: 'rare', management: 'Seek immediate medical attention' },
    ],
    cautions: {
      cardiac: 'Orthostatic hypotension, arrhythmias',
      other: ['History of priapism', 'Cardiovascular disease'],
    },
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Serotonin syndrome', recommendation: 'Wait 14 days' },
      { drug: 'CYP3A4 inhibitors', severity: 'moderate', mechanism: 'Increased trazodone levels', recommendation: 'May need dose reduction' },
    ],
    clinicalPearls: [
      'Commonly used off-label for insomnia at low doses',
      'Not typically used as antidepressant due to sedation',
      'Priapism risk - counsel patients to seek immediate care',
      'Minimal anticholinergic effects',
      'No REM sleep suppression',
    ],
    monitoring: [
      { parameter: 'Blood pressure', baseline: true, followUp: 'Check orthostatic if symptomatic', frequency: 'As needed' },
    ],
    pregnancyCategory: 'C',
    qtRisk: 'none',
    citations: ['Insomnia Guidelines'],
    updatedAt: '2024-01-15',
  },
  // Additional medications (abbreviated)
  {
    id: 'risperidone',
    name: 'Risperidone',
    genericName: 'Risperdal',
    tags: ['Atypical Antipsychotic', 'First-line psychosis'],
    class: 'Atypical Antipsychotic',
    indications: ['Schizophrenia', 'Bipolar Mania', 'Autism (irritability)', 'Dementia (off-label)'],
    quickFlags: ['First-line', 'Weight-gain', 'QT-safe'],
    dosing: {
      adult: {
        start: '1 mg BID or 2 mg daily',
        titration: 'Increase by 1-2 mg every 2-3 days',
        maintenance: '4-6 mg/day',
        max: '16 mg/day',
      },
      geriatric: {
        start: '0.25 mg BID',
        maintenance: '0.5-2 mg/day',
        notes: 'Start very low',
      },
    },
    warnings: ['Hyperprolactinemia', 'EPS at higher doses', 'Metabolic effects'],
    sideEffects: [
      { effect: 'Prolactin elevation', frequency: 'very-common' },
      { effect: 'Weight gain', frequency: 'common' },
      { effect: 'EPS', frequency: 'common', management: 'More common at doses >6mg' },
    ],
    cautions: { other: ['Parkinson disease', 'Prolactin-dependent tumors'] },
    interactions: [],
    clinicalPearls: ['Monitor prolactin if symptoms', 'Higher EPS risk than other atypicals', 'Long-acting injectable available'],
    monitoring: [
      { parameter: 'Prolactin', baseline: false, followUp: 'If symptoms (galactorrhea, amenorrhea, sexual dysfunction)', frequency: 'As needed' },
      { parameter: 'Weight', baseline: true, followUp: 'Monitor quarterly', frequency: 'Quarterly' },
    ],
    qtRisk: 'none',
    citations: ['Schizophrenia Guidelines'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'buspirone',
    name: 'Buspirone',
    genericName: 'Buspar',
    tags: ['Anxiolytic', 'Non-benzodiazepine'],
    class: 'Anxiolytic',
    indications: ['Generalized Anxiety Disorder'],
    quickFlags: ['First-line GAD', 'No dependence', 'QT-safe', 'Weight-neutral'],
    dosing: {
      adult: {
        start: '7.5 mg BID',
        titration: 'Increase by 5 mg every 2-3 days',
        maintenance: '15-30 mg/day (divided BID-TID)',
        max: '60 mg/day',
      },
      renal: 'Reduce dose',
      hepatic: 'Reduce dose',
    },
    warnings: ['Delayed onset (2-4 weeks)', 'Not effective for panic disorder or acute anxiety'],
    sideEffects: [
      { effect: 'Dizziness', frequency: 'common' },
      { effect: 'Nausea', frequency: 'common' },
      { effect: 'Headache', frequency: 'common' },
      { effect: 'Activation', frequency: 'common' },
    ],
    cautions: {},
    interactions: [
      { drug: 'MAOIs', severity: 'contraindicated', mechanism: 'Hypertensive crisis', recommendation: 'Avoid' },
      { drug: 'CYP3A4 inhibitors', severity: 'moderate', mechanism: 'Increased levels', recommendation: 'Reduce dose' },
    ],
    clinicalPearls: ['No dependence or withdrawal', 'Delayed onset like antidepressants', 'Not useful PRN', 'Good for GAD in patients with substance use history'],
    qtRisk: 'none',
    citations: ['CANMAT Anxiety 2014'],
    updatedAt: '2024-01-15',
  },
  {
    id: 'valproate',
    name: 'Valproate / Divalproex',
    genericName: 'Depakote',
    tags: ['Mood Stabilizer', 'Anticonvulsant', 'Antimanic'],
    class: 'Mood Stabilizer',
    indications: ['Acute Mania', 'Bipolar Disorder (maintenance)', 'Seizure Disorders', 'Migraine Prophylaxis'],
    quickFlags: ['First-line mania', 'Weight-gain', 'QT-safe', 'Teratogenic'],
    dosing: {
      adult: {
        start: '250 mg TID or 500 mg BID (delayed release)',
        titration: 'Increase by 250-500 mg/day based on levels',
        maintenance: '750-2000 mg/day',
        max: '60 mg/kg/day',
      },
      notes: 'Target levels: 50-125 mcg/mL (mania), 50-100 mcg/mL (maintenance)',
    },
    warnings: [
      'Hepatotoxicity (rare but fatal)',
      'Pancreatitis',
      'Teratogenic - neural tube defects (avoid in pregnancy)',
      'Hyperammonemia',
      'Thrombocytopenia',
    ],
    sideEffects: [
      { effect: 'Weight gain', frequency: 'very-common' },
      { effect: 'Hair loss', frequency: 'common', management: 'Supplement with zinc/selenium' },
      { effect: 'Tremor', frequency: 'common' },
      { effect: 'Sedation', frequency: 'common' },
    ],
    cautions: {
      hepatic: 'Contraindicated in liver disease',
      other: ['Pregnancy', 'Urea cycle disorders', 'Mitochondrial disorders'],
    },
    interactions: [
      { drug: 'Aspirin', severity: 'major', mechanism: 'Increased valproate levels', recommendation: 'Monitor levels' },
      { drug: 'Carbapenems', severity: 'major', mechanism: 'Decreased valproate levels', recommendation: 'Avoid if possible' },
      { drug: 'Lamotrigine', severity: 'major', mechanism: 'Inhibits lamotrigine metabolism', recommendation: 'Reduce lamotrigine dose by 50%' },
    ],
    clinicalPearls: ['First-line for acute mania', 'Monitor levels and LFTs', 'Avoid in pregnancy - major teratogen', 'May cause polycystic ovary syndrome'],
    monitoring: [
      { parameter: 'Valproate level', baseline: false, followUp: 'Check after dose changes', frequency: 'Every 3-6 months' },
      { parameter: 'Liver enzymes', baseline: true, followUp: 'Monitor for hepatotoxicity', frequency: 'Every 3-6 months' },
      { parameter: 'CBC/platelets', baseline: true, followUp: 'Monitor for thrombocytopenia', frequency: 'Every 3-6 months' },
      { parameter: 'Ammonia', baseline: false, followUp: 'If confusion/lethargy', frequency: 'As needed' },
    ],
    pregnancyCategory: 'X',
    qtRisk: 'none',
    citations: ['CANMAT Bipolar 2018'],
    updatedAt: '2024-01-15',
  },
];

export const medicationClasses = [
  { id: 'SSRI', name: 'SSRIs', description: 'Selective Serotonin Reuptake Inhibitors', color: 'blue' },
  { id: 'SNRI', name: 'SNRIs', description: 'Serotonin-Norepinephrine Reuptake Inhibitors', color: 'cyan' },
  { id: 'Atypical Antidepressant', name: 'Atypical Antidepressants', description: 'Novel mechanism antidepressants', color: 'purple' },
  { id: 'Atypical Antipsychotic', name: 'Atypical Antipsychotics', description: 'Second-generation antipsychotics', color: 'amber' },
  { id: 'Mood Stabilizer', name: 'Mood Stabilizers', description: 'Bipolar disorder treatments', color: 'green' },
  { id: 'Benzodiazepine', name: 'Benzodiazepines', description: 'Anxiolytics and sedatives', color: 'slate' },
  { id: 'Anxiolytic', name: 'Non-BZD Anxiolytics', description: 'Anxiety treatments without dependence', color: 'teal' },
  { id: 'Stimulant', name: 'Stimulants', description: 'ADHD treatments', color: 'orange' },
];

export const indications = [
  'Major Depressive Disorder',
  'Bipolar Disorder',
  'Bipolar Depression',
  'Acute Mania',
  'Schizophrenia',
  'Generalized Anxiety Disorder',
  'Panic Disorder',
  'Social Anxiety Disorder',
  'PTSD',
  'OCD',
  'ADHD',
  'Insomnia',
  'Alcohol Withdrawal',
];

export const quickFlags = [
  { id: 'First-line', name: 'First-line', color: 'green', description: 'First-line treatment option' },
  { id: 'Second-line', name: 'Second-line', color: 'amber', description: 'Second-line or adjunctive option' },
  { id: 'Pregnancy-safe', name: 'Pregnancy Safe', color: 'blue', description: 'Generally safe in pregnancy' },
  { id: 'QT-safe', name: 'QT Safe', color: 'green', description: 'Minimal QT prolongation risk' },
  { id: 'QT-caution', name: 'QT Caution', color: 'amber', description: 'Use caution with other QT drugs' },
  { id: 'Weight-neutral', name: 'Weight Neutral', color: 'green', description: 'Minimal weight effects' },
  { id: 'Weight-loss', name: 'Weight Loss', color: 'blue', description: 'May cause weight loss' },
  { id: 'Weight-gain', name: 'Weight Gain', color: 'red', description: 'Significant weight gain risk' },
  { id: 'Activating', name: 'Activating', color: 'orange', description: 'May cause insomnia/anxiety' },
  { id: 'Sedating', name: 'Sedating', color: 'purple', description: 'May cause drowsiness' },
];
